Results 31 to 40 of about 192,839 (256)

Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy

Clinical Ophthalmology, 2023
Tomoko Miyakubo, Ryo Mukai, Hidetaka Matsumoto, Masahiro Morimoto, Maki Takahashi, Kazuki Nagai, Kosuke Nakamura, Junki Hoshino, Hideo Akiyama Department of Ophthalmology, Gunma University, Graduate School of Medicine, Maebashi, Gunma ...
Miyakubo T, Mukai R, Matsumoto H, Morimoto M, Takahashi M, Nagai K, Nakamura K, Hoshino J, Akiyama H   +8 more
doaj  

Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion

Ophthalmology and Therapy, 2019
Introduction To report the 52-week treatment outcomes with intravitreal injections of aflibercept using a treat-and-extend regimen for treating macular edema secondary to central retinal vein occlusion (CRVO). Methods A retrospective analysis of patients
Maria Eleftheriadou, Luke Nicholson, Giulia D’Alonzo, Peter K. F. Addison   +3 more
doaj   +1 more source

Five-year outcome of aflibercept intravitreal injection in naïve patients with neovascular age-related macular degeneration using a modified treat-and-extend regimen: Results from a prospective observational study

Taiwan Journal of Ophthalmology, 2023
PURPOSE: The purpose is to study the 5-year results of aflibercept monotherapy using an individualized regimen in naïve patients with neovascular AMD (nAMD). MATERIALS AND METHODS: This is a prospective observational study including naïve nAMD patients
Jarret Charles, TRAN Thi Ha Chau
doaj   +1 more source

Age, Initial Central Retinal Thickness, and OCT Biomarkers Have an Influence on the Outcome of Diabetic Macular Edema Treated With Ranibizumab– Tri-center 12-Month Treat-and-Extend Study

Frontiers in Medicine, 2021
Objective: We report the tri-center 1-year outcomes of a treat-and-extend (T&E) regimen in four-week intervals with ranibizumab for diabetic macular edema (DME).Methods: In this retrospective study, all eyes received 3 monthly loading injections of 0.
Chun-Ting Lai, Yi-Ting Hsieh, Chun-Ju Lin, Chun-Ju Lin, Chun-Ju Lin, Jia-Kang Wang, Jia-Kang Wang, Chih-Ying Lin, Chih-Ying Lin, Ning-Yi Hsia, Ning-Yi Hsia, Henry Bair, Huan-Sheng Chen, Chiung-Yi Chiu, Shao-Wei Weng   +14 more
doaj   +1 more source

Two-year outcomes of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema [PDF]

Scientific Reports, 2020
AbstractThis study was performed to investigate the efficacy of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema (DME). This prospective, multicentre, interventional, single-arm, 104-week clinical trial included 48 patients with DME visual impairment.
Yu Cheol Kim, Jae Pil Shin, Kang Yeun Pak, Hyun Woong Kim, Min Sagong, Sang Joon Lee, In Young Chung, Sung Who Park, Ji Eun Lee   +8 more
openaire   +3 more sources

Treat-and-Extend Intravitreal Bevacizumab for Branch Retinal Vein Occlusion

Ophthalmic Surgery, Lasers and Imaging Retina, 2014
BACKGROUND AND OBJECTIVE: To determine the effectiveness and direct medical costs of treat-and-extend (TAE) intravitreal bevacizumab (IVB) for the treatment of branch retinal vein occlusion (BRVO)–associated macular edema (ME). PATIENTS AND METHODS: Retrospective chart review of 52 ...
Rush, R, Simunovic, M, Aragon, A, Ysasaga, J   +3 more
openaire   +3 more sources

Pharmacoeconomic research of using aflibercept in patients with the wet age-related macular degeneration

Российский офтальмологический журнал, 2020
Purpose. To evaluate the economic and clinical results of the aflibercept and ranibizumab angiogenesis inhibitors in the treat-and-extend regimen in patients with the “wet” form of age-related macular degeneration (wAMD). Materials and methods.
S. V. Nedogoda, A. S. Salasyuk, E. V. Bobykin, I. N. Barykina, V. O. Smirnova, E. A. Popova   +5 more
doaj   +1 more source

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan

BMC Ophthalmology, 2022
The management of neovascular age-related macular degeneration (nAMD) has taken a major stride forward with the advent of anti-VEGF agents. The treat-and-extend (T&E) approach is a refined management strategy, tailoring to the individual patient’s ...
Cheng-Kuo Cheng, Shih-Jen Chen, Jiann-Torng Chen, Lee-Jen Chen, San-Ni Chen, Wen-Lu Chen, Sheng-Min Hsu, Chien-Hsiung Lai, Shwu-Jiuan Sheu, Pei-Chang Wu, Wei-Chi Wu, Wen-Chuan Wu, Chung-May Yang, Ling Yeung, Ta-Ching Chen, Chang-Hao Yang   +15 more
doaj   +1 more source

A simulation tool for better management of retinal services

BMC Health Services Research, 2018
Background Advances in the management of retinal diseases have been fast-paced as new treatments become available, resulting in increasing numbers of patients receiving treatment in hospital retinal services. These patients require frequent and long-term
Eren Demir, David Southern, Aimee Verner, Winfried Amoaku   +3 more
doaj   +1 more source

Primary lymphoma of the liver treated with extended left hepatic lobectomy [PDF]

Cancer, 1985
Primary lymphoma of the liver is an extremely rare entity; only five cases have been reported in the English language literature. Presented is a case report of a patient with primary hepatic lymphoma successfully treated by major liver resection. The current management trends are reviewed.
S J, Daniel, F F, Attiyeh, J J, Dire, H J, Pyun, D S, Carroll, A, Attia   +5 more
openaire   +2 more sources